Perceptive Advisors Q2 2022 holdings

$3.19 Billion is the total value of Perceptive Advisors's 111 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 34.1% .

 Value Shares↓ Weighting
 TRAVERE THERAPEUTICS INCnote 2.250% 3/0$455,940
-3.8%
45,000,0000.0%14.28%
+50.4%
FOLD SellAMICUS THERAPEUTICS INC$288,858
+10.7%
26,895,532
-2.4%
9.05%
+73.1%
MRTX BuyMIRATI THERAPEUTICS INC$192,453
-1.7%
2,866,863
+20.4%
6.03%
+53.7%
CERE  CEREVEL THERAPEUTICS HLDNG I$134,493
-24.5%
5,086,7270.0%4.21%
+18.1%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$130,562
-35.7%
11,826,299
-3.1%
4.09%
+0.5%
BuyLIANBIOsponsored ads$122,170
-41.5%
56,560,211
+0.4%
3.83%
-8.6%
CRNX BuyCRINETICS PHARMACEUTICALS IN$99,237
-12.4%
5,321,032
+3.1%
3.11%
+36.9%
GBT SellGLOBAL BLOOD THERAPEUTICS IN$96,331
-28.6%
3,015,054
-22.5%
3.02%
+11.7%
SWTX SellSPRINGWORKS THERAPEUTICS INC$95,217
-62.7%
3,867,446
-14.6%
2.98%
-41.7%
BuyAMYLYX PHARMACEUTICALS INC$68,188
+260.0%
3,540,408
+140.2%
2.14%
+463.6%
XENE SellXENON PHARMACEUTICALS INC$64,568
-12.4%
2,122,535
-12.0%
2.02%
+36.9%
MGTX BuyMEIRAGTX HLDGS PLC$52,712
-45.2%
6,963,277
+0.2%
1.65%
-14.3%
LYRA BuyLYRA THERAPEUTICS INC$51,679
+298.9%
9,146,730
+183.8%
1.62%
+522.7%
BLU SellBELLUS HEALTH INC NEW$51,136
-8.7%
5,534,169
-32.0%
1.60%
+42.9%
RXDX SellPROMETHEUS BIOSCIENCES INC$47,490
-48.5%
1,682,242
-31.1%
1.49%
-19.4%
ALBO  ALBIREO PHARMA INC$46,872
-33.4%
2,360,1390.0%1.47%
+4.1%
 CINCOR PHARMA INC$43,692
+7.4%
2,319,1170.0%1.37%
+67.9%
VBIV  VBI VACCINES INC CDA$42,312
-51.3%
52,335,0020.0%1.32%
-23.9%
SGEN NewSEAGEN INC$39,635224,000
+100.0%
1.24%
VERU SellVERU INC$39,550
+87.7%
3,500,000
-19.8%
1.24%
+193.6%
ALDX  ALDEYRA THERAPEUTICS INC$39,516
-10.2%
9,903,8790.0%1.24%
+40.4%
NBIX BuyNEUROCRINE BIOSCIENCES INC$38,786
+4.6%
397,888
+0.6%
1.22%
+63.5%
RAPT SellRAPT THERAPEUTICS INC$34,927
-43.3%
1,913,791
-31.6%
1.09%
-11.3%
RLAY  RELAY THERAPEUTICS INC$32,546
-44.0%
1,943,0970.0%1.02%
-12.5%
LLY NewLILLY ELI & CO$32,423100,000
+100.0%
1.02%
 COHERUS BIOSCIENCES INCnote 1.500% 4/1$29,484
-33.9%
4,500,0000.0%0.92%
+3.4%
COGT SellCOGENT BIOSCIENCES INC$27,863
+16.7%
3,088,972
-3.1%
0.87%
+82.6%
CHRS SellCOHERUS BIOSCIENCES INC$26,393
-56.5%
3,645,471
-22.4%
0.83%
-31.9%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$26,306
-3.7%
367,501
+32.1%
0.82%
+50.6%
ALNY SellALNYLAM PHARMACEUTICALS INC$25,231
-14.2%
172,991
-3.9%
0.79%
+34.1%
SellPROCEPT BIOROBOTICS CORP$24,508
-52.9%
749,700
-49.6%
0.77%
-26.4%
NAUT  NAUTILUS BIOTECHNOLOGY INC$24,508
-38.0%
9,111,1510.0%0.77%
-3.0%
ADMA SellADMA BIOLOGICS INC$22,812
+4.5%
11,521,102
-3.5%
0.71%
+63.4%
SellNUVALENT INC$22,442
-7.8%
1,655,007
-5.5%
0.70%
+44.4%
ESTA SellESTABLISHMENT LABS HLDGS INC$22,065
-27.3%
405,759
-9.9%
0.69%
+13.7%
ZYME SellZYMEWORKS INC$21,902
-37.2%
4,132,534
-22.4%
0.69%
-1.9%
IMTX  IMMATICS N.V$21,775
+9.0%
2,500,0000.0%0.68%
+70.5%
INBX BuyINHIBRX INC$21,731
-45.2%
1,914,592
+7.5%
0.68%
-14.3%
NewARCELLX INC$20,6471,141,990
+100.0%
0.65%
ISEE SellIVERIC BIO INC$20,086
-77.2%
2,087,956
-60.0%
0.63%
-64.3%
HRMY NewHARMONY BIOSCIENCES HLDGS IN$20,084411,804
+100.0%
0.63%
TARS  TARSUS PHARMACEUTICALS INC$18,927
-13.2%
1,296,4160.0%0.59%
+35.7%
CRY BuyARTIVION INC$17,553
+33.3%
929,705
+51.0%
0.55%
+108.3%
SellDICE THERAPEUTICS INC$16,326
-43.7%
1,051,904
-30.6%
0.51%
-12.0%
RCKT SellROCKET PHARMACEUTICALS INC$16,056
-39.7%
1,166,883
-30.5%
0.50%
-5.6%
BBIO SellBRIDGEBIO PHARMA INC$15,409
-60.5%
1,697,033
-55.8%
0.48%
-38.2%
BMRN NewBIOMARIN PHARMACEUTICAL INC$14,917180,000
+100.0%
0.47%
OM SellOUTSET MED INC$14,841
-82.6%
998,727
-47.0%
0.46%
-72.9%
ATHA BuyATHIRA PHARMA INC$14,632
-68.4%
4,797,278
+40.0%
0.46%
-50.5%
APLS SellAPELLIS PHARMACEUTICALS INC$14,529
-80.7%
321,300
-78.3%
0.46%
-69.8%
TVTX SellTRAVERE THERAPEUTICS INC$13,813
-71.0%
570,084
-69.1%
0.43%
-54.6%
RAIN  RAIN THERAPEUTICS INC$13,809
+9.7%
2,483,6190.0%0.43%
+71.8%
TMCI SellTREACE MED CONCEPTS INC$13,497
-26.5%
941,192
-3.1%
0.42%
+14.9%
OMIC SellSINGULAR GENOMICS SYSTEMS IN$13,509
-41.4%
3,536,274
-3.3%
0.42%
-8.4%
VRNA SellVERONA PHARMA PLCsponsored ads$12,214
-19.6%
2,915,146
-4.2%
0.38%
+26.0%
VRDN SellVIRIDIAN THERAPEUTICS INC$11,244
-57.3%
971,832
-31.7%
0.35%
-33.2%
CCXI SellCHEMOCENTRYX INC$10,945
-73.6%
441,680
-73.3%
0.34%
-58.7%
CMAX SellCAREMAX INC$10,890
-54.3%
3,000,000
-5.9%
0.34%
-28.5%
LABP  LANDOS BIOPHARMA INC$10,823
-50.7%
14,869,9150.0%0.34%
-22.8%
DAWN  DAY ONE BIOPHARMACEUTICALS I$9,953
+80.4%
556,0470.0%0.31%
+183.6%
VRCA BuyVERRICA PHARMACEUTICALS INC$9,675
-67.0%
5,038,983
+39.6%
0.30%
-48.4%
LPTX  LEAP THERAPEUTICS INC$9,144
-34.3%
7,951,4480.0%0.29%
+2.5%
CNCE  CONCERT PHARMACEUTICALS INC$9,054
+24.9%
2,150,6410.0%0.28%
+95.9%
 ISOPLEXIS CORP$8,846
-37.0%
4,095,4980.0%0.28%
-1.4%
KRON  KRONOS BIO INC$8,812
-49.7%
2,421,1420.0%0.28%
-21.4%
NewHILLEVAX INC$8,360764,907
+100.0%
0.26%
SLDB  SOLID BIOSCIENCES INC$8,257
-48.7%
13,412,5520.0%0.26%
-19.6%
PRVA BuyPRIVIA HEALTH GROUP INC$7,962
+39.6%
273,423
+28.1%
0.25%
+118.4%
RVNC BuyREVANCE THERAPEUTICS INC$7,912
+195.0%
572,514
+316.3%
0.25%
+359.3%
MORF SellMORPHIC HLDG INC$7,881
-74.4%
363,197
-52.7%
0.25%
-60.0%
XBI NewSPDR SER TRput$7,427100,000
+100.0%
0.23%
PNT SellPOINT BIOPHARMA GLOBAL INC$7,314
-23.1%
1,073,995
-10.1%
0.23%
+19.9%
 SOMALOGIC INC$6,780
-43.6%
1,500,0000.0%0.21%
-12.0%
HCAT SellHEALTH CATALYST INC$6,740
-47.7%
465,162
-5.8%
0.21%
-18.2%
BuySEMA4 HOLDINGS CORP$6,300
-17.9%
5,000,000
+100.0%
0.20%
+27.9%
SellICOSAVAX INC$5,976
-38.4%
1,042,850
-24.4%
0.19%
-3.6%
CCCC SellC4 THERAPEUTICS INC$5,777
-88.6%
766,231
-63.2%
0.18%
-82.1%
NUVB  NUVATION BIO INC$5,733
-38.4%
1,769,7010.0%0.18%
-3.2%
ATNX  ATHENEX INC$5,540
-50.6%
13,532,4670.0%0.17%
-22.7%
ACRS SellACLARIS THERAPEUTICS INC$4,764
-27.9%
341,239
-11.0%
0.15%
+12.9%
NBTX  NANOBIOTIXsponsored ads$4,027
-48.9%
1,059,8000.0%0.13%
-20.3%
QTNT  QUOTIENT LTD$3,888
-80.0%
16,200,8180.0%0.12%
-68.6%
 ASTRIA THERAPEUTICS INC$3,843
-55.3%
1,281,1970.0%0.12%
-30.2%
 PYXIS ONCOLOGY INC$3,639
-41.1%
1,528,8120.0%0.11%
-8.1%
MGNX SellMACROGENICS INC$3,620
-73.7%
1,227,202
-21.3%
0.11%
-58.9%
 TYRA BIOSCIENCES INC$3,535
-33.2%
494,4030.0%0.11%
+4.7%
CLOV  CLOVER HEALTH INVESTMENTS CO$3,210
-39.7%
1,500,0000.0%0.10%
-5.6%
YMAB NewY-MABS THERAPEUTICS INC$3,208212,018
+100.0%
0.10%
 SCIENCE 37 HOLDINGS INC$3,015
-62.4%
1,500,0000.0%0.09%
-41.6%
 ENVVENO MEDICAL CORPORATION$2,954
-40.7%
781,6150.0%0.09%
-7.0%
SellABSCI CORPORATION$2,969
-70.4%
894,346
-24.9%
0.09%
-53.7%
SAVA NewCASSAVA SCIENCES INCput$2,812100,000
+100.0%
0.09%
FUSN SellFUSION PHARMACEUTICALS INC$2,621
-72.5%
1,052,445
-14.2%
0.08%
-57.1%
SellHYPERFINE INC$2,530
-52.4%
1,134,388
-24.4%
0.08%
-25.5%
ABOS SellACUMEN PHARMACEUTICALS INC$2,390
+2.4%
508,532
-14.8%
0.08%
+59.6%
RLMD SellRELMADA THERAPEUTICS INC$2,304
-43.6%
121,350
-19.8%
0.07%
-12.2%
 DARIOHEALTH CORP$2,013
+5.1%
327,8690.0%0.06%
+65.8%
FULC  FULCRUM THERAPEUTICS INC$1,441
-79.3%
294,1180.0%0.04%
-67.6%
SellPEAR THERAPEUTICS INC$1,386
-70.4%
900,548
-2.8%
0.04%
-54.3%
RACE  FERRARI N V$1,138
-15.8%
6,2000.0%0.04%
+33.3%
SellSONENDO INC$1,115
-58.4%
648,505
-3.0%
0.04%
-35.2%
ZY  ZYMERGEN INC$1,086
-57.5%
883,3320.0%0.03%
-33.3%
TARA SellPROTARA THERAPEUTICS INC$850
-56.6%
290,051
-24.4%
0.03%
-30.8%
NewAGILE THERAPEUTICS INC$620532,361
+100.0%
0.02%
MOTS  MOTUS GI HLDGS INC$507
-21.8%
1,800,5420.0%0.02%
+23.1%
PRVB SellPROVENTION BIO INC$443
-92.4%
110,728
-86.0%
0.01%
-87.9%
 EQRX INC*w exp 12/17/202$203
-6.9%
250,0000.0%0.01%
+50.0%
NewNEPTUNE WELLNESS SOLUTIONS I$8157,142
+100.0%
0.00%
 SURROZEN INC*w exp 08/01/203$32
-23.8%
166,6660.0%0.00%0.0%
SellSURROZEN INC$18
-92.3%
6,017
-92.3%
0.00%
-80.0%
CMAXW  CAREMAX INC*w exp 06/08/202$43
-62.3%
60,0000.0%0.00%
-50.0%
BFLYWS ExitBUTTERFLY NETWORK INC*w exp 02/12/202$0-233,333
-100.0%
-0.01%
ExitMINERVA SURGICAL INC$0-50,268
-100.0%
-0.01%
ExitSOMALOGIC INC*w exp 08/31/202$0-110,000
-100.0%
-0.01%
NEPT ExitNEPTUNE WELLNESS SOLUTIONS I$0-2,000,000
-100.0%
-0.01%
ExitROCKLEY PHOTONICS HOLDINGS L*w exp 08/11/202$0-500,000
-100.0%
-0.01%
ExitRAPID MICRO BIOSYSTEMS INC$0-190,745
-100.0%
-0.03%
ONCR ExitONCORUS INC$0-752,241
-100.0%
-0.03%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-44,475
-100.0%
-0.03%
GRPH ExitGRAPHITE BIO INC$0-325,854
-100.0%
-0.03%
PRTA ExitPROTHENA CORP PLC$0-65,144
-100.0%
-0.05%
NARI ExitINARI MED INC$0-30,000
-100.0%
-0.05%
ExitIMMUNEERING CORP$0-681,051
-100.0%
-0.09%
HSAQ ExitHEALTH SCIENCES ACQ CORP 2$0-450,000
-100.0%
-0.09%
NVTA ExitINVITAE CORP$0-554,585
-100.0%
-0.09%
ExitSIGHT SCIENCES INC$0-390,000
-100.0%
-0.09%
ExitDA32 LIFE SCNCE TEC ACQSTN C$0-500,000
-100.0%
-0.10%
MRUS ExitMERUS N V$0-209,046
-100.0%
-0.11%
ACCD ExitACCOLADE INC$0-330,682
-100.0%
-0.12%
ACAD ExitACADIA PHARMACEUTICALS INC$0-284,853
-100.0%
-0.14%
EVH ExitEVOLENT HEALTH INCcl a$0-250,000
-100.0%
-0.16%
RACB ExitRESEARCH ALLIANCE CORP II$0-1,000,000
-100.0%
-0.20%
SMIHU ExitSUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026$0-1,000,000
-100.0%
-0.20%
BLSA ExitBCLS ACQUISITION CORP$0-1,000,000
-100.0%
-0.20%
ExitCUE HEALTH INC$0-1,580,607
-100.0%
-0.20%
ExitNANOSTRING TECHNOLOGIES INCnote 2.625% 3/0$0-1,000,000
-100.0%
-0.22%
RCUS ExitARCUS BIOSCIENCES INC$0-405,000
-100.0%
-0.26%
LUNG ExitPULMONX CORP$0-537,779
-100.0%
-0.27%
AXNX ExitAXONICS INC$0-341,211
-100.0%
-0.43%
LEGN ExitLEGEND BIOTECH CORPsponsored ads$0-616,141
-100.0%
-0.45%
ZNTL ExitZENTALIS PHARMACEUTICALS INC$0-501,509
-100.0%
-0.46%
PEN ExitPENUMBRA INC$0-143,591
-100.0%
-0.64%
NVRO ExitNEVRO CORP$0-477,037
-100.0%
-0.69%
ExitCOLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1$0-9,500,000
-100.0%
-1.79%
HZNP ExitHORIZON THERAPEUTICS PLC$0-1,357,903
-100.0%
-2.86%
AGRX ExitAGILE THERAPEUTICS INC$0-21,294,485
-100.0%
-3.57%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Joseph Edelman — Managing Member

Compare quarterly holdings

Export Perceptive Advisors's holdings

EDGAR filings